Galera Therapeutics, Inc. Common Stock
GRTX
GRTX was delisted on the 3rd of June, 2024.
38 hedge funds and large institutions have $1.53M invested in Galera Therapeutics, Inc. Common Stock in 2023 Q3 according to their latest regulatory filings, with 8 funds opening new positions, 7 increasing their positions, 12 reducing their positions, and 24 closing their positions.
400% more call options, than puts
Call options by funds: $10K | Put options by funds: $2K
31% less funds holding
Funds holding: 55 → 38 (-17)
42% less repeat investments, than reductions
Existing positions increased: 7 | Existing positions reduced: 12
67% less first-time investments, than exits
New positions opened: 8 | Existing positions closed: 24
97% less capital invested
Capital invested by funds: $57.8M → $1.53M (-$56.2M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
HF
HRT Financial
New York
|
+$239K |
| 2 |
Invesco
Atlanta,
Georgia
|
+$182K |
| 3 |
KAS
Kestra Advisory Services
Austin,
Texas
|
+$107K |
| 4 |
FDCDDQ
Federation des caisses Desjardins du Quebec
Levis,
Quebec, Canada
|
+$62.1K |
| 5 |
MF
Manchester Financial
Westlake Village,
California
|
+$62K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
NHAS
Novo Holdings A/S
Hellerup,
Denmark
|
-$6.55M |
| 2 |
SAM
Sectoral Asset Management
Montreal,
Quebec, Canada
|
-$6.26M |
| 3 |
Alyeska Investment Group
Chicago,
Illinois
|
-$5.3M |
| 4 |
VCIM
Velan Capital Investment Management
Alpharetta,
Georgia
|
-$3.12M |
| 5 |
PHP
Parkman Healthcare Partners
Stamford,
Connecticut
|
-$1.69M |
GRTX Hedge Fund Activity: Q3 2023 in Review
38 of the 6,302 institutional investors tracked by Wall St. Rank reported a position in Galera Therapeutics, Inc. Common Stock (GRTX) for Q3 2023, worth a combined $1.53M — down 97% from $57.8M a quarter earlier.
Sellers outnumbered buyers: 24 funds closed out of GRTX and 8 opened new positions — a net loss of 16 holders — while 12 trimmed existing stakes and 7 added.
The largest buyer was HRT Financial, opening a new position worth an estimated $239K. The largest seller was Novo Holdings A/S, exiting entirely with an estimated $6.55M sold.
- 38 institutional investors held Galera Therapeutics, Inc. Common Stock (GRTX) as of Q3 2023, down from 55 in Q2 2023.
- Funds reported $1.53M of Galera Therapeutics, Inc. Common Stock stock for Q3 2023, down 97% quarter-over-quarter.
- 8 funds opened new Galera Therapeutics, Inc. Common Stock positions in Q3 2023 and 24 closed out, a net change of -16 holders.
- The largest Galera Therapeutics, Inc. Common Stock buyer in Q3 2023 was HRT Financial, an estimated $239K added.
- The largest Galera Therapeutics, Inc. Common Stock seller in Q3 2023 was Novo Holdings A/S, an estimated $6.55M sold.
Based on aggregated 13F filings for Q3 2023.